- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06391606
CoQ10 in Statin-associated Asthenia
Effect of Coenzyme Q10 on Physical Performance in Elderly Patients With Statin-associated Asthenia: a Double-blind, Randomized, Placebo-controlled Clinical Trial
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
BO
-
Bologna, BO, Italy, 40138
- University of Bologna
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion criteria:
- 65-80 years of age
- treatment for >6 months with statin monotherapy (i.e. enrolled individuals were asked to be on the same statin at the same dosage for >6 months)
- statin-associated asthenia for >3 months
Exclusion criteria:
- serious or disabling diseases (e.g. severe organ failure, malignancy or dementia)
- orthopedic disorders, myopathies and any other acute or chronic disease that could significantly affect the individual's perception of asthenia
- obesity (body mass index (BMI)> 30 Kg/m2)
- known gastrointestinal disorders potentially affecting the absorption of CoQ10
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Coenzyme Q10
2 pills of 150 mg CoQ10 phytosome (i.e.
300 mg CoQ10 phytosome per day)
|
2 pills/day of 150 mg CoQ10 phytosome (i.e.
300 mg CoQ10 phytosome per day)
|
|
Placebo Comparator: Placebo
2 pills of placebo per day
|
2 pills/day
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Effect on handgrip strength
Time Frame: 8 weeks
|
We evaluated the effect on handgrip strength after 8 weeks of dietary supplementation with CoQ10 phytosome compared to either baseline and placebo. A hand-held dynamometer was used to assess handgrip strength. Measurements were assessed according to the International standard protocols, and obtained after participants performed one familiarization trial with both hands. |
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Effect on handgrip strength
Time Frame: 4 weeks
|
We evaluated the effect on handgrip strength after 4 weeks of dietary supplementation with CoQ10 phytosome compared to either baseline and placebo. A hand-held dynamometer was used to assess handgrip strength. Measurements were assessed according to the International standard protocols, and obtained after participants performed one familiarization trial with both hands. |
4 weeks
|
|
Effect on statin-associated asthenia
Time Frame: 4 weeks
|
We evaluated the effect on asthenia after 4 weeks of dietary supplementation with CoQ10 phytosome compared to either baseline and placebo. Asthenia was assessed on a 10-point visual analogue scale (VAS), considering 0= absence of asthenia and 10= extreme asthenia. |
4 weeks
|
|
Effect on statin-associated asthenia
Time Frame: 8 weeks
|
We evaluated the effect on asthenia after 8 weeks of dietary supplementation with CoQ10 phytosome compared to either baseline and placebo. Asthenia was assessed on a 10-point visual analogue scale (VAS), considering 0= absence of asthenia and 10= extreme asthenia. |
8 weeks
|
|
Effect on 1-min sit-to-stand repetitions
Time Frame: 4 weeks
|
We evaluated the effect on 1-min sit-to-stand repetitions after 4 weeks of dietary supplementation with CoQ10 phytosome compared to either baseline and placebo.
|
4 weeks
|
|
Effect on 1-min sit-to-stand repetitions
Time Frame: 8 weeks
|
We evaluated the effect on 1-min sit-to-stand repetitions after 8 weeks of dietary supplementation with CoQ10 phytosome compared to either baseline and placebo.
|
8 weeks
|
|
Effect on 2-minute step test
Time Frame: 4 weeks
|
We evaluated the effect on 2-minute step test after 4 weeks of dietary supplementation with CoQ10 phytosome compared to either baseline and placebo.
|
4 weeks
|
|
Effect on 2-minute step test
Time Frame: 8 weeks
|
We evaluated the effect on 2-minute step test after 8 weeks of dietary supplementation with CoQ10 phytosome compared to either baseline and placebo.
|
8 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Claudio Borghi, MD, PhD, University of Bologna
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- QELD_Stat_2017
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypercholesterolemia
-
National Medical Research Center for Therapy and...Moscow State University of Medicine and DentistryActive, not recruitingMedication Adherence | Adherence, Medication | Treatment Adherence | Familial Hypercholesterolemia | Motivational Interviewing | Adherence, Patient | Treatment Adherence and Compliance | Patient Compliance | Adherence | Hypercholesterolemia, Familial | Patient Adherence | Hypercholesterolemia, Autosomal Dominant and other conditionsRussian Federation
-
Institut Investigacio Sanitaria Pere VirgiliRecruitingFamilial Hypercholesterolemia | Familial Hypercholesterolemia - Homozygous | Familial Hypercholesterolemia - HeterozygousSpain
-
Direct PlantesUnknownHYPERCHOLESTEROLEMIAFrance
-
Novartis PharmaceuticalsNot yet recruitingDyslipidemia, Hypercholesterolemia
-
Shanghai General Hospital, Shanghai Jiao Tong University...Accuredit Therapeutics US LimitedNot yet recruitingHeterozygous Familial HypercholesterolemiaChina
-
Addpharma Inc.Not yet recruitingPrimary Hypercholesterolemia
-
Chong Kun Dang PharmaceuticalRecruitingPrimary HypercholesterolemiaKorea, Republic of
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Salubris (Chengdu) Biotechnology Co., Ltd.CompletedHypercholesterolemia and Mixed DyslipidemiaChina
-
Provident Clinical ResearchGlaxoSmithKlineCompletedPrimary HypercholesterolemiaUnited States
-
Addpharma Inc.CompletedPrimary HypercholesterolemiaKorea, Republic of
Clinical Trials on Coenzyme Q10
-
3i SolutionsKGK Science Inc.Not yet recruitingBioavailability Heathy Volunteers | Pharmacokinetic ParametersCanada
-
Tang-Du HospitalNot yet recruiting
-
University of SumerCompletedMale InfertilityIraq
-
Zahra NejatiKurdistan University of Medical Sciences; Hady Mohammadi, Director of oral... and other collaboratorsNot yet recruitingTemporomandibular Joint Disorders | Molar, Third | Dry Socket | Coenzyme Q10
-
Ain Shams UniversityCompletedSystemic Lupus ErythematosusEgypt
-
Damanhour UniversityCompletedBreast Cancer | Chemotherapeutic ToxicityEgypt
-
Alexandria UniversityRecruiting
-
University of ShizuokaCompletedHemodialysis | Chronic Renal FailureJapan
-
Central Hospital, Nancy, FranceCompletedCyclic Vomiting SyndromeFrance
-
Hadassah Medical OrganizationUnknown